NICE Guidance - Nivolumab for previously treated advanced renal cell carcinoma: (c) NICE (2017) Nivolumab for previously treated advanced renal cell carcinoma

[Anonymous]

BJU INTERNATIONAL, 2018; 122 (3): 362